
CBD: Hype or Hope?

There’s a big mismatch between what people use and what we’re actually studying.
Full Session

Setup
Suddenly, CBD is everywhere – it’s being sold in major drugstore chains and showing up in skin lotion, smoothies, baked goods, lozenges, pet food, and Ben & Jerry’s ice cream. Some people swear by CBD to treat inflammation, anxiety, pain, sleep disorders, epilepsy, diabetes, high blood pressure, and just about everything else. Derived from the cannabis plant, it is part of a class that also includes THC, the psychoactive ingredient in marijuana. The US Food and Drug Administration held its first public hearing on CBD in early June, but doesn’t yet regulate the product, and concerns about mislabeling and other hazards abound. What does the science tell us about CBD? Is the $600 million market a triumph of hype or a hopeful promise?
Speakers
-
Mallory LoflinResearch Scientist and Principal Investigator, Veterans Affairs San Di...
-
Hunter LandAssociate Director of Cannabinoid Research, Canopy Growth Corporation
-
Marcel Bonn-MillerGlobal Scientific Director, Canopy Growth Corporation; Assistant Profe...
-
Matt LasloFreelance Reporter; Contributor, Rolling Stone ; Adjunct Political Co...
- 2019 Health
- Science
Explore More
Science
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...


















